Binary dose-response data often exhibit extrabinomial variation when the responses arise naturally in groups or \litters." This paper investigates the use of generalized Wald and score statistics for robustifying the standard inference methods based on the binomial likelihood. Special attention is given to the probit analysis of a parallel assay of the teratogenic e ects on mice of several dioxins.
Introduction
Logistic regression and probit analysis are often used in dose-response modeling of binary responses where binomial likelihoods form the basis for a well-developed theory of estimation and inference (e.g., Cox and Snell, 1989 , Hosmer and Lemeshow, 1989 , and Santner and Du y, 1989 . In certain situations, however, the binary responses arise naturally in groups or \litters" and a binomial likelihood description of the data is not correct due to induced correlations within litters. If Y is the number of \successes" in a litter of size n with E(Y jn) = np, then typically Var(Y jn) > np(1?p), and the data are said to have extra-binomial variation (see Haseman and Kupper, 1979) . For example, the data in Figure 1 are from a study on the teratogenic e ects of certain chemicals including 2,3,7,8-tetrabromodibenzo-p-dioxin (TBDD) in C57BL/6N mice (Birnbaum, Morrissey, and Harris, 1990) . The responses are the proportions Y=n of cleft palate incidence in each litter for pregnant dams treated on gestation day 10 and examined on gestation day 18. Also plotted in Figure 1 are similar data for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) from Birnbaum (1989) . One of the goals of the statistical analysis of these data was to estimate the relative potency of TBDD to TCDD after determining if a probit model with common slope could be t to the data. We shall see in Section 3 that these data exhibit considerable extra-binomial variation which upsets the usual binomial likelihood inference. One possible result of using standard packaged programs based on the binomial model would be that the assumption of common slope could be rejected due to underestimation of the variability. Another result would be that con dence intervals for the relative potency would be too narrow. A number of di erent methods have been developed to deal with extra-binomial variation. For example, the binomial model can be expanded to a beta-binomial model and likelihood techniques used (see Haseman and Kupper, 1979, Segreti and Munson, 1981) , or the mean-variance relationship may be modeled and generalized linear model methods used (see Williams, 1982) , or the extra-binomial aspect can be handled by bootstrap techniques (Carr, 1989) . The approach of this paper is to use the binomial likelihood for estimation but to robustify inferences by using empirical variance estimates which do not rely on the binomial assumption. This general approach is fairly standard (e.g., Kent, 1982 , White, 1982 , Royall, 1986 , Liang and Zeger, 1986 , and its use in binomial regression contexts is developing quite rapidly (e.g., Prentice, 1988 , Rotnitzky and Jewell, 1990 , Moore and Tsiatis, 1991 . It is similar in spirit to common adjustments for heterogeneity or overdispersion (Finney, 1971, p. 72, McCullagh and Nelder, 1989, p. 127) but is more general because it allows for di erent amounts of extra-variation to be estimated at each dose level. Moreover, it ts into a general theory for estimating equations as described in Boos (1990) . Although the methods discussed are appropriate for the general binomial regression context, I will emphasize dose-response modeling with data having replication at each dose-treatment combination. The paper is organized as follows. Section 2 introduces the notation and general approach and develops tests about regression parameters. Section 3 then discusses tests for extra-binomial variation and goodness-of-t tests for adequacy of the mean speci cation in the presence of extrabinomial variation. The methods are illustrated throughout with the data from Figure 1 .
The Model and Inference Method
Assume that there are k dose levels, where at the ith dose d i we observe fY ij , n ij , j=1,...,m i g.
In order that results will be fairly general for the binomial regression context, we let the ith dose If the Y ij are distributed as independent binomial random variables, then the log likelihood is
Taking partial derivatives, the maximum likelihood estimator^ solves
where p 0 i ( ) = dF(z)=dzj z=x T i . The negative of the Hessian of l( ) is
where p 00 i ( ) = d 2 F(z)=dz 2 j z=x T i .
When evaluated at^ , this latter quantity is the observed information and will be denoted bŷ 
(The required regularity conditions are similar to those for the binomially distributed case which may be found in Fahrmeir and Kaufman, 1985.) (1) whereV 22 is from the appropriate partition ofV . Score and likelihood ratio tests are often preferred to Wald tests because of parameter invariance and Type I error considerations. Since likelihood ratio tests do not generalize easily to handle misspeci cation (see Kent, 1982) , I will focus on score test generalizations. Rao's (1948) Although T GS has a somewhat complex appearance, it may be derived from simple Taylor expansions of S( ) (see Breslow, 1990, p. 567, and Boos, 1990 , for details). Kent (1982, p. 23 Table   1 to robustly estimate variances. Analysis of the actual extra-binomial variation is deferred until the next section. For a parallel assay one hopes that a common slope and two intercepts will provide an adequate t to the data. In the rst part of Table 2 are given p-values for the Wald and score tests for the common slope hypothesis and also for the linear versus quadratic hypothesis. The Wald tests require that the larger 4-parameter models be tted, whereas the score tests only require that the smaller 3-parameter models be tted. I used SAS NLIN to get the parameter estimates and then SAS IML for the matrix manipulations. The entry labeled \SAS" is from PROC PROBIT in SAS 6.03. The Wald p-values for this entry are based on an estimated covariance matrix adjusted for heterogeneity as explained in Finney (1971, p. 72) . All tests here suggest that neither separate slopes nor a quadratic term help improve the t very much. f . The standard errors from SAS PROC PROBIT using the heterogeneity correction factor are between those fromÎ ?1 f andV . It is worth noting that Finney (1971, Sec. 9 .1) presents an extended analysis using the individual Y ij values to estimate the heterogeneity factor which yields results close to those based onV for this example. This extended analysis, however, is not standard output from SAS PROC PROBIT. The last part of Table 2 gives the median e ective dose (ED50) for TBDD, 65.2=expf14.16/3.39g, and for TCDD, 15.4=expf9.26/3.39g, and the relative potency, 4.25=expf(14.16{9.26)/3.39g. The con dence intervals are constructed using Fieller's Theorem as outlined in Finney (1971, p.78) . Note that the relative potency con dence interval (3.61,4.81) based onV is considerably larger than the interval (3.89,4.64) based onÎ ?1 f .
Model Adequacy
Two Pearson chi-squared statistics for testing adequacy of the mean model E(Y ij jn ij ; x i ) = n ij p i ( ) = n ij F(x T i ) with the binomial likelihood structure are 6 0 7 12 2 7 12 1 7 18 9 10 6 0 8 12 4 9 12 0 6 18 5 7 6 0 9 12 2 10 15 7 10 18 10 10 6 0 10 12 0 7 15 3 5 18 1 7 6 0 5 12 0 10 15 3 9 18 6 7 6 0 9 12 3 8 15 6 6 18 0 10 6 0 8 12 5 7 15 2 7 18 3 8 6 0 9 12 3 8 15 7 10 18 8 10 6 0 10 12 1 6 15 1 8 18 5 8 6 0 10 12 1 11 15 2 10 18 11 11 6 0 10 12 1 3 18 5 5 12 0 10 12 0 9 18 10 10 Either of these statistics will be sensitive to both mean speci cation and to extra-binomial variation. I think it is helpful, however, to separate the distributional part from the mean speci cation since typically the mean speci cation is the focus of the investigation. Although Section 2 shows how to study the mean part without requiring the binomial assumptions to hold, it can be of interest to check the binomial assumption and perhaps quantify the extent of the extra-binomial variation. I will rst illustrate the latter with the example data and then discuss methods for assessing the mean t.
The binomial 
See Tarone (1979) for other appropriate test statistics. Table 3 
The factor m i =(m i ? 1) has been added so that if the n ij have a common value, then (4) is an unbiased estimate of Var(Y i: jn i1 ; : : :; n im i ). In that case the Var Ratio is just the component of 2 c for that dose divided by m i ? 1 and thus equal to the heterogeneity factor for that dose. The di erences between 2 =(df ? 1) and the Var Ratio are small except for TBDD at Dose=96 where there are three n ij equal to 3 and the rest lie between 7 and 10. Dose 18 for TCDD seems to have considerably more overdispersion than the other dose-treatment combinations. Note also Note: The \ 2 " entries are the components of 2 c in (3), and the \G 2 " entries are the analogous ?2 log(likelihood ratio) values. The \Var Ratio" entries are de ned in (5).
that (4) is the unstructured version ofV =Î ?1 fD YÎ ?1 f given in Section 2 and closely related to the jackknife variance estimator of Gladen (1979) . Now we turn to checking the adequacy of the mean speci cation E(Y ij jn ij ; x i ) = n ij F(x T i ). In a standard binomial analysis, one would typically use 2 a in (2) to assess adequacy of the mean. Here we want to develop tests for mean adequacy without assuming that the data are binomial.
The form of the generalized score statistic T GS given in Section 2 for testing H 0 : 2 = 0 is not appropriate here since we want to test F 0 = Diag dF(z) dz z=x T i~ ; i = 1; : : :; k :
The general form for T GS in this context is derived in Boos (1990) Rewrite (6) as T GS = T GS1 ? T GS2 , where T GS1 = S(~ ) TD?1 Y S(~ ). If the mean speci cation and binomial likelihood are both correct, then T GS1 is asymptotically equivalent to the Pearson statistic 2 a in (1), and T GS2 converges to zero in probability as the cell sizes m i tend to in nity. Table 4 . This is a case where Y i: = 1=142 = :007 and p i (^ ) = :00035. If that single cleft palate had not occurred, then 2 a = 0:32 and T GS = 0:10 yielding much more similar results for the two statistics. In fact one should perhaps look at some relevant case-deletion diagnostics (e.g., Williams, 1987) .
It is interesting that the log likelihood ratio G 2 does not seem to have the same sensitivity to that one cell as does its analogue 2 a : 4.10 versus 18.06 in the rst row of Table 4 . SAS PROC PROBIT prints out G 2 but keys on 2 a and uses the heterogeneity factor 19:4=8 = 2:43 to multiply I ?1 for inference purposes as seen in Table 2 parts 2) and 3). In a sense, the inference based on the heterogeneity factor brings the analysis closer to my analysis based on empirical variances but seemingly for the wrong reasons (i.e., mean lack-of-t in that one cell). For those who try to reproduce the results of Table 4 , note that SAS PROC PROBIT actually gives G 2 =5.6655 and 2 a = 19:4454 based on all 11 dose-treatment combinations. Lastly, I reran all the analyses for a logit model in place of the probit model and got similar results using my methods, but 2 a = 2:66 for the logit compared to 2 a = 19:45 for the probit model (formally on 8 degrees of freedom, but as mentioned above I think 3 degrees of freedom is more appropriate). Thus a standard binomial analysis would not use the heterogeneity factor for inference with the logit model for these data, and con dence limits for the ED50's which are based onĨ f are too narrow.
Discussion
Inference for dose-response models in the presence of extra-binomial variation is easily carried out using empirical variances. No enlarged models such as the beta-binomial or the inclusion of a variance function are required. Either Wald or score tests may be used for testing nested hypotheses about the mean as shown in Section 2. For the goodness-of-t tests in Section 3 it is useful to have replication at each dose-treatment combination as in the example data. Replication also helps in the estimates ofD in Section 2 although it is not essential. SAS code with comments is available from the author for the computations of Section 2.
